Surrogate endpoint in advanced hepatocellular carcinoma treated with molecular targeted therapy: Meta-analysis of randomized controlled trials.

被引：0
|
作者：
Lee, Kyung-Hun
Lee, Dae-Won
Jang, Myoung-Jin
Kim, Tae-Yong
Han, Sae-Won
Oh, Do-Youn
Im, Seock-Ah
Kim, Tae-You
机构：
[1] Seoul Natl Univ Hosp, Seoul, South Korea
[2] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
[3] Seoul Natl Univ Hosp, Internal Med, Seoul, South Korea
[4] Seoul Natl Univ Hosp, Dept Med, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 04期
关键词：
D O I：
10.1200/JCO.2017.35.4_suppl.454
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
454
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Current Treatments for Small Hepatocellular Carcinoma: A Network Meta-Analysis of Randomized Controlled Trials
    Guo, Z.
    Zheng, Z.
    He, X.
    Chen, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 213 - 213
  • [32] Ranking of transarterial and targeted therapies for advanced hepatocellular carcinoma in the era of immuno-oncology: A network meta-analysis of randomized sorafenib-controlled trials
    An, Jihyun
    Han, Seungbong
    Kim, Ha Il
    Shim, Ju Hyun
    HEPATOLOGY COMMUNICATIONS, 2022, 6 (10) : 2886 - 2900
  • [33] Surrogate endpoints for overall survival in advanced hepatocellular carcinoma: A meta-analysis
    Saleh, Yacob
    Baskurt, Zeynep
    Farooq, Abdul Rehman
    Goodwin, Rachel Anne
    Knox, Jennifer J.
    Chen, Eric X.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 563 - 563
  • [34] Comparison of checkpoint inhibitor-based regimens as first-line therapy in advanced hepatocellular carcinoma: A Frequentist Network meta-analysis of randomized clinical trials.
    Ali, Muhammad Ashar
    Aiman, Wajeeha
    Ali, Mukarram Jamat
    Anwar, Muhammad Yasir
    Shaaban, Hamid Salim
    Guron, Gunwant K.
    Maroules, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [35] Efficacy and safety of second-line therapies for advanced hepatocellular carcinoma: a network meta-analysis of randomized controlled trials
    Lu, Fenping
    Zhao, Kai
    Ye, Miaoqing
    Xing, Guangyan
    Liu, Bowen
    Li, Xiaobin
    Ran, Yun
    Wu, Fenfang
    Chen, Wei
    Hu, Shiping
    BMC CANCER, 2024, 24 (01)
  • [36] Selection of first-line systemic therapies for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials
    Yue Han
    Wei-Hua Zhi
    Fei Xu
    Chen-Bo Zhang
    Xiao-Qian Huang
    Jian-Feng Luo
    World Journal of Gastroenterology, 2021, 27 (19) : 2415 - 2433
  • [37] Selection of first-line systemic therapies for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials
    Han, Yue
    Zhi, Wei-Hua
    Xu, Fei
    Zhang, Chen-Bo
    Huang, Xiao-Qian
    Luo, Jian-Feng
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (19) : 2415 - 2433
  • [38] COMPARISON OF FIRSTLINE SYSTEMIC THERAPIES FOR ADVANCED HEPATOCELLULAR CARCINOMA: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Hur, Moon Haeng
    Park, Youngsu
    Ko, Yunmi
    Shin, Hyunjae
    Park, Jeayeon
    Kim, Ju Yeon
    Lee, Yun Bin
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Lee, Jeong-Hoon
    HEPATOLOGY, 2023, 78 : S1821 - S1821
  • [39] Second-line Treatments of Advanced Hepatocellular Carcinoma Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
    Bakouny, Ziad
    Assi, Tarek
    El Rassy, Elie
    Nasr, Fadi
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2019, 53 (04) : 251 - 261
  • [40] Immune checkpoint inhibitors therapy in advanced bladder carcinoma: A meta-analysis of phase III randomized controlled trials
    Patel, Rushin
    Chitkara, Akshit
    Patel, Zalak
    Patel, Mrunal
    Anamika, Fnu
    Trivedi, Shivang
    Ramaswamy, Bhuvaneswari
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345